Relmada Therapeutics, Inc. (RLMD)
- Previous Close
0.3572 - Open
0.3511 - Bid 0.2574 x 200
- Ask 0.4260 x 200
- Day's Range
0.3241 - 0.3700 - 52 Week Range
0.2400 - 4.4700 - Volume
611,536 - Avg. Volume
1,767,231 - Market Cap (intraday)
11.415M - Beta (5Y Monthly) 0.18
- PE Ratio (TTM)
-- - EPS (TTM)
-2.6500 - Earnings Date May 8, 2025 - May 12, 2025
- Forward Dividend & Yield --
- Ex-Dividend Date --
- 1y Target Est
0.87
Relmada Therapeutics, Inc. operates as a clinical-stage biotechnology company. It focuses on the development of NDV-01, a controlled-release intravesical formulation of gemcitabine and docetaxel, which is in Phase 2 clinical trial in patients with aggressive forms of non-muscle invasive bladder cancer; and Sepranolone, a neurosteroid epimer of allopregnanolone for the potential treatment of Prader-Willi Syndrome, Tourette Syndrome, excessive tremor, and other diseases related to excessive GABAergic activity. The company is headquartered in Coral Gables, Florida.
www.relmada.comRecent News: RLMD
View More
Performance Overview: RLMD
Trailing total returns as of 5/7/2025, which may include dividends or other distributions. Benchmark is S&P 500 (^GSPC) .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: RLMD
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: RLMD
View MoreValuation Measures
Market Cap
11.41M
Enterprise Value
-33.49M
Trailing P/E
--
Forward P/E
--
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
--
Price/Book (mrq)
0.32
Enterprise Value/Revenue
--
Enterprise Value/EBITDA
--
Financial Highlights
Profitability and Income Statement
Profit Margin
0.00%
Return on Assets (ttm)
-73.14%
Return on Equity (ttm)
-132.33%
Revenue (ttm)
--
Net Income Avi to Common (ttm)
-79.98M
Diluted EPS (ttm)
-2.6500
Balance Sheet and Cash Flow
Total Cash (mrq)
44.91M
Total Debt/Equity (mrq)
--
Levered Free Cash Flow (ttm)
-23.85M
Research Analysis: RLMD
View MoreResearch Reports: RLMD
View MoreDaily – Vickers Top Insider Picks for 12/09/2024
The Vickers Top Insider Picks is a daily report that utilizes a proprietary algorithm to identify 25 companies with compelling insider purchase histories based on transactions over the past three months.
Daily – Vickers Top Insider Picks for 12/06/2024
The Vickers Top Insider Picks is a daily report that utilizes a proprietary algorithm to identify 25 companies with compelling insider purchase histories based on transactions over the past three months.
Daily – Vickers Top Insider Picks for 12/05/2024
The Vickers Top Insider Picks is a daily report that utilizes a proprietary algorithm to identify 25 companies with compelling insider purchase histories based on transactions over the past three months.
Daily – Vickers Top Insider Picks for 12/04/2024
The Vickers Top Insider Picks is a daily report that utilizes a proprietary algorithm to identify 25 companies with compelling insider purchase histories based on transactions over the past three months.